Ny studie om hypotyreose som er såkalt borderline, subklinisk og latent på norsk http://www.ncbi.nlm.nih.gov/pubmed/23824418
De har gått gjennom masse forskning om subklinisk hypotyreose og sammenliknet data.
These data suggest, by extrapolation, that carefully monitored treatment of even modest elevations of TSH may have substantial health benefits. Appropriately powered large-scale clinical trials analyzing the risks vs benefits of treating subclinical thyroid disease are required to determine whether these benefits can be achieved with levothyroxine therapy.